Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, primarily affecting individuals with chronic liver diseases such as cirrhosis and hepatitis B or C. In Long Island, Queens, and Levittown, NY, it’s essential for at-risk populations to remain informed about symptoms and early detection methods to enhance treatment success. This information will provide a comprehensive understanding of HCC evaluation and treatment options available at our practice. The incidence of liver cancer in the United States has more than tripled since 1990, making it the fastest-growing cause of cancer-related death in the country.
Truly one of the best, he is very well educated and well spoken, he diagnosed me when TWO other gastroenterologists couldn’t. His staff is very friendly as well. His office is also very clean and well taken care of. He cares about his patients and is very deserving of more than 5 stars.
Hepatocellular Carcinoma Symptoms and Early Detection
Hepatocellular carcinoma symptoms can vary widely; early stages may not present any noticeable signs. However, as the disease progresses, individuals may experience abdominal pain, weight loss, loss of appetite, jaundice, and fatigue. Regular liver cancer screenings are vital, particularly for those with existing risk factors such as hepatitis infections or cirrhosis.
Identify Risk Factors for Hepatocellular Carcinoma
Understanding the risk factors associated with HCC is crucial for prevention and early detection. Key risk factors include:
- Chronic hepatitis B or C infection
- Cirrhosis of the liver
- Heavy alcohol consumption
- Obesity and metabolic syndrome
- Exposure to aflatoxins
Individuals in the Long Island area should be aware that maintaining a healthy liver through lifestyle choices can significantly reduce their risk of developing liver cancer. Our lead physician, Dr. Mit Shah, is a member of the American Gastroenterological Association and brings extensive expertise in liver diseases.
Hepatocellular Carcinoma Diagnosis in Long Island
Diagnosing hepatocellular carcinoma typically involves a combination of imaging studies—such as ultrasound, CT scan, or MRI—and liver biopsy. Our practice in Queens and Levittown utilizes these advanced diagnostic approaches to detect HCC early. Recognizing the disease promptly allows for appropriate staging, which is critical to determining the best course of treatment. The five-year survival rate for HCC varies by stage: 37.3% for localized disease, 40% for regional disease, and only 3.3% for distant disease.
Explore Comprehensive Treatment Options for HCC
The treatment options for hepatocellular carcinoma depend on the stage of cancer and the overall health of the liver. In our practice, we offer a range of treatment modalities, including:
- Surgical resection
- Liver transplantation
- Ablation therapies
- Embolization techniques
- Targeted therapies and immunotherapy
Our team is dedicated to tailoring treatment plans that reflect the individual needs of each patient, maximizing the potential for successful management. Our team, led by board-certified gastroenterologists Dr. Davinder Singh, ensures evidence-based treatment strategies aimed at improving patient outcomes.
Innovative Therapies for Liver Cancer Management
Our gastroenterology practice in Long Island stays at the forefront of innovations in liver cancer treatment. We continuously explore cutting-edge therapies, such as immunotherapy and targeted therapy, which have shown promise in managing advanced HCC. We encourage patients to consider clinical trials as a potential option for treatment, providing access to new therapies that may not yet be widely available. In 2025, an estimated 42,240 new cases of liver and intrahepatic bile duct cancer are expected in the United States.
Understanding the Role of Clinical Trials for HCC
Clinical trials play a vital role in advancing the treatment of hepatocellular carcinoma. In our practice, we actively participate in studies that aim to develop new therapeutic strategies for HCC. These clinical trials not only provide patients with access to emerging treatments but also contribute to the broader understanding of liver cancer management. Patients in Long Island can discuss clinical trial options with our experienced team.
FAQs about Hepatocellular Carcinoma at Our Practice
-
Hepatocellular carcinoma (HCC) is a primary liver cancer that typically develops in individuals with underlying liver diseases such as cirrhosis and chronic hepatitis.
-
Diagnosis of HCC involves imaging tests and possibly a liver biopsy to understand the extent of the disease and to determine the best treatment options.
-
Treatment may include surgery, liver transplantation, local ablation therapies, embolization, and systemic treatments like chemotherapy or immunotherapy.
-
Yes, participation in clinical trials can provide access to innovative therapies for HCC. Our practice is involved in ongoing studies that aim to advance treatment options.
-
Maintaining a healthy lifestyle, managing chronic liver diseases, and avoiding excessive alcohol consumption can significantly reduce the risk of developing HCC.
Why Choose Our Gastroenterology Practice for HCC
At our practice in Long Island, we pride ourselves on a patient-centered approach to hepatocellular carcinoma care. Our team, led by board-certified gastroenterologists Dr. Mit Shah and Dr. Davinder Singh, brings extensive training and experience in diagnosing and treating liver diseases. With a strong focus on evidence-based medicine and innovative treatment methods, we ensure our patients receive the most effective care for HCC. Our practice has also been recognized for its contributions to the field, receiving awards for excellence from the American College of Gastroenterology.
Having served the community for several years, our practice has established a reputation for excellence, supported by our participation in numerous professional associations, including the American Gastroenterological Association and the American Association for the Study of Liver Disease.
About UsTake the Next Step Towards Healthier Liver Care
If you are concerned about hepatocellular carcinoma or would like to learn more about our comprehensive treatment options available in Long Island, Queens, and Levittown, NY, we encourage you to reach out to our gastroenterology team. Schedule your consultation today with our knowledgeable professionals who are dedicated to providing you with the least invasive and most effective care possible.
